Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA marketing clearance for ChemTrak :

This article was originally published in Clinica

Executive Summary

ChemTrak's Accumeter theophylline test has received FDA marketing clearance. The test is carried out on whole blood and is able to measure the concentration of theophylline, used as a bronchodilator and respiratory stimulant by acute or chronic asthmatics, with 99% accuracy. Unlike previous tests, the Accumeter is designed for use in a physician's office laboratory. One of the most common blood tests, about 35 million tests for theophylline serum concentration were performed in the US in 1990.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086575

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel